Back to Results
First PageMeta Content
Monoclonal antibodies / Molecular biology / Biotechnology / Immunosuppressants / Tumor necrosis factor-alpha / TNF inhibitor / Rheumatoid arthritis / Adalimumab / Vector / Biology / Medicine / Gene delivery


Follow-up Discussion of Serious Adverse Event OBA Protocol Number 705
Add to Reading List

Document Date: 2014-01-14 14:54:11


Open Document

File Size: 60,86 KB

Share Result on Facebook
UPDATE